Viewing Study NCT01188733


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-31 @ 5:26 AM
Study NCT ID: NCT01188733
Status: COMPLETED
Last Update Posted: 2010-08-25
First Post: 2010-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cirrhosis View
None Portal Hypertension View
None Esophageal Varices View
Keywords:

Keywords

Keyword Brief Keyword Text View
None portal hypertension View
None varices View
None cirrhosis View
None octreotide View
None somatostatin analog View
None Child Pugh Class A,B View